[Oral anticoagulation in the secondary prevention of stroke].
This review considers secondary prevention of ictus based on the use of oral anticoagulant drugs. For this, we analyze separately the secondary preventive aspects of the two most frequent ischemic aetiologies: cardioembolic and atherothrombotic infarcts.
Chamorro
A
A
Servicio de Neurología, Hospital Clínic de Barcelona, España.
D000284:Administration, Oral; D000368:Aged; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D055502:Secondary Prevention; D020521:Stroke / Q000517:prevention & control*
D010975:Platelet Aggregation Inhibitors